Utah Medical Products IncUTMD

NasdaqHealthcareSurgical & Medical Instruments & Apparatus
Price (close)
$74.75
Market cap
$238.0M
P/E
22.7x
Revenue (TTM)
$36.1M
Net income
$10.5M
Dividend yield
1.66%
1-year total return
22.0%
Net margin
29.0%
Revenue growth
-7.0%
Debt / equity
0.00x

What Utah Medical Products Inc does.

Utah Medical Products, Inc. (“UTMD” or “the Company”) is in the business of producing high quality cost-effective medical devices that are predominantly differentiated by safety and improved patient outcomes. Throughout this report, “UTMD” or “the Company” refers jointly to Utah Medical Products, Inc. and all of its corporate subsidiaries. Success depends on 1) recognizing and responding to needs of clinicians and patients, 2) rapidly designing or acquiring economical solutions that gain premarketing regulatory concurrence, 3) reliably producing devices that meet those clinical needs, and then 4) selling through

a) UTMD's own direct channels into markets where the Company enjoys an established reputation and has a critical mass of sales and support resources, or

b) relationships with other companies that have the resources to effectively distribute and support the Company's devices.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue$42.2M$49.1M$52.3M$50.2M$40.9M$38.5M
Net income$10.8M$14.8M$16.5M$16.6M$13.9M$11.3M
Free cash flow$19.3M$20.7M$20.3M$21.6M$14.6M$14.3M

More on UTMD.

Figures from Utah Medical Products Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.